Activation and role of caspases in chemotherapy-induced apoptosis

Drug Resistance Updates

Volumn 2, Issue 1, 1999, Pages 21-29

  Schmitt, Estelle ^a   Sané, Alain Théophile ^a   Bertrand, Richard ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CASPASE; CISPLATIN; CYTARABINE; CYTOCHROME C; DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; FAS ANTIGEN; GYRASE INHIBITOR; PACLITAXEL; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; VINBLASTINE;

APOPTOSIS; CANCER; CANCER CHEMOTHERAPY; CELL DEATH; ENZYME ACTIVATION; HUMAN; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 0033082063     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.1999.0065     Document Type: Article

References (84)

1. Kerr J. F., Wyllie A. H., Currie A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:1972;239-257.
2. Rudin C. M., Thompson C. B. Apoptosis and disease - Regulation and clinical relevance of programmed cell death. Ann Rev Med. 48:1997;267-281.
3. Reed J. C. Bcl-2 family proteins - Regulators of apoptosis and chemoresistance in hematologic malignancies. Seminars in Hematology. 34:1997;9-19.
4. Hengartner M. O., Ellis R. E., Horvitz H. R. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature. 356:1992;494-496.
5. Yuan J., Horvitz H. R. The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death. Development 1992;116:309-320.
6. Yuan, J. Shaham, S. Ledoux, S. The Celegans, 1993, 75, 641, 652.
7. Conradt, B. Horvitz, H. R. The C elegans, 1998, 93, 519-529.
8. Chao D. T., Korsmeyer S. J. BCL-2 family - regulators of cell death. Annu Rev Immunol. 16:1998;395-419.
9. Reed J. C., Jurgensmeier J. M., Matsuyama S. BCL-2 family proteins and mitochondria. Biochim Biophys Acta. 1366:1998;127-137.
10. Alnemri E. S. Mammalian cell death proteases - a family of highly conserved aspartate specific cysteine proteases. J Cell Biochem. 64:1997;33-42.
11. Cryns V., Yuan J. Y. Proteases to die for. Genes Dev. 12:1998;1551-1570.
12. Stennicke H. R., Salvesen G. S. Properties of the caspases. Biochim Biophys Acta. 1387:1998;17-31.
13. Zou, H. Henzel, W. J. Liu, X. S. Apaf-1, a human protein homologous to C elegans, 1997, 90, 405-413.
14. Chinnaiyan A. M., Orourke K., Lane B. R., Dixit V. M. Interaction of Ced-4 with Ced-3 and Ced-9 - a molecular framework for cell death. Science. 275:1997;1122-1126.
15. Li P., Nijhawan D., Budihardjo I. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
16. Pan G. H., Orourke K., Dixit V. M. Caspase-9, Bcl-X-L, and Apaf-1 form a ternary complex. J Biol Chem. 273:1998;5841-5845.
17. Hu Y. M., Benedict M. A., Wu D. Y., Inohara N., Nunez G. Bcl-X-L interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Nat Acad Sci USA. 95:1998;4386-4391.
18. Bergeron L., Perez G. I., Macdonald G. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Devel. 12:1998;1304-1314.
19. Kuida K., Zheng T. S., Na S. Q. Decreased apoptosis in the brain and premature lethality in Cpp32-deficient mice. Nature. 384:1996;368-372.
20. Varfolomeev E. E., Schuchmann M., Luria V. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and Dr3 and is lethal prenatally. Immunity. 9:1998;267-276.
21. Kuida K., Haydar T. F., Kuan C. Y. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell. 94:1998;325-337.
22. Hakem R., Hakem A., Duncan G. S. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell. 94:1998;339-352.
23. Kuida K., Lippke J. A., Ku G. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science. 267:1995;2000-2003.
24. Wang S. Y., Miura M., Jung Y. K., Zhu H., Li E., Yuan J. Y. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell. 92:1998;501-509.
25. Zamzami N., Brenner C., Marzo I., Susin S. A., Kroemer G. Subcellular and submitochondrial mode of action of bcl-2-like oncoproteins. Oncogene. 16:1998;2265-2282.
26. Cecconi F., Alvarezbolado G., Meyer B. I., Roth K. A., Gruss P. Apaf-1 (Ced-4 homolog) regulates programmed cell death in mammalian development. Cell. 94:1998;727-737.
27. Yoshida H., Kong Y. Y., Yoshida R. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell. 94:1998;739-750.
28. Thornberry N. A., Ranon T. A., Pieterson E. P. A combinatorial approach defines specificities of members of the caspase family and granzyme B - functional relationships established for key mediators of apoptosis. J Biol Chem. 272:1997;17907-17911.
29. Liu X. S., Zou H., Slaughter C., Wang X. D. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell. 89:1997;175-184.
30. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A. Caspase-activated DNAse that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 391:1998;43-50.
31. Halenbeck R., Macdonald H., Roulston A., Chen T. T., Conroy L., Wiiliams L. T. CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45. Curr Biol. 8:1998;537-540.
32. Wright S. C., Wei Q. S., Zhong J., Zheng H., Kinder D. H., Larrick J. W. Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation. J Exp Med. 180:1994;2113-2123.
33. Sane A. T., Bertrand R. Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities. Cancer Res. 58:1998;3066-3072.
34. 2+-dependent endonuclease (AN34) from etoposide-treated human leukemia HL-60 cells undergoing apoptosis. Cancer Res. 58:1998;2576-2582.
35. Dole M. G., Jasty R., Cooper M. J., Thompson C. B., Nunez G., Castle V. P. Bcl-X(L) is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res. 55:1995;2576-2582.
36. Ibrado A. M., Huang Y., Fang G. F., Bhalla K. Bcl-X(L) overexpression inhibits taxol-induced YAMA protease activity and apoptosis. Cell Growth Diff. 7:1996;1087-1094.
37. Simonian P. L., Grillot D. A. M., Nunez G. Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death. Blood. 90:1997;1208-1216.
38. Schmitt E., Cimoli G., Steyaert A., Bertrand R. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities. Exp Cell Res. 240:1998;107-121.
39. Schmitt E., Steyaert A., Cimoli G., Bertrand R. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells. Cell Death Diff. 5:1998;506-516.
40. Susin S. A., Zamzami N., Kroemer G. Mitochondria as regulators of apoptosis - doubt no more. Biochim Biophys Acta. 1366:1998;151-165.
41. Decaudin D., Marzo I., Brenner C., Kroemer G. Mitochondria in chemotherapy-induced apoptosis - a prospective novel target of cancer therapy. Int J Oncol. 12:1998;141-152.
42. Vanderheiden M. G., Chandel N. S., Williamson E. K., Schumacker P. T., Thompson C. B. Bcl-X(L) regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91:1997;627-637.
43. Liu X., Kim C. N., Yang J., Wang X. Induction of apoptotic program in cell-free extracts:requirement for dATP and cytochrome c. Cell. 86:1996;147-157.
44. Srinivasula S. M., Ahmad M., Fernandes-Alnemri T., Alnemri E. S. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell. 1:1998;949-957.
45. Pan G. H., Humke E. W., Dixit V. M. Activation of caspases triggered by cytochrome c in vitro. FEBS Letters. 426:1998;151-154.
46. Kluck R. M., Bossywetzel E., Green D. R., Newmeyer D. D. The release of cytochrome c from mitochondria - a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
47. Yang J., Liu X. S., Bhalla K. Prevention of apoptosis by Bcl-2 - release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
48. Kharbanda S., Pandey P., Schofield L. Bcl-X(L) as an inhibitor of cytosolic cytochrome c accumulation in DNA damage-induced apoptosis. Proc Nat Acad Sci (USA). 94:1997;6939-6942.
49. Rosse T., Olivier R., Monney L. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature. 391:1998;496-499.
50. Xiang J. L., Chao D. T., Korsmeyer S. J. Bax-induced cell death may not require interleukin 1-beta-converting enzyme-like proteases. Proc Nat Acad Sci (USA). 93:1996;14559-14563.
51. Jurgensmeier J. M., Xie Z. H., Deveraux Q., Ellerby L., Bredesen D., Reed J. C. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Nat Acad Sci (USA). 95:1998;4997-5002.
52. Bossywetzel E., Newmeyer D. D., Green D. R. Mitochondrial cytochrome C release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17:1998;37-49.
53. Marzo I., Susin S. A., Petit P. X. Caspases disrupt mitochondrial membrane barrier function. FEBS Letters. 427:1998;198-202.
54. Wu D. Y., Wallen H. D., Nunez G. Interaction and regulation of subcellular localization of Ced-4 by Ced-9. Science. 275:1997;1126-1129.
55. Zhivotovsky B., Orrenius S., Brustugun O. T., Doskeland S. O. Injected cytochrome c induces apoptosis. Nature. 391:1998;449-450.
56. Ashkenazi A., Dixit V. M. Death receptors - signaling and modulation. Science. 281:1998;1305-1308.
57. Pan G. H., Bauer J. H., Haridas V. Identification and functional characterization of Dr6, a novel death domain-containing TNF receptor. FEBS Letters. 431:1998;351-356.
58. Muzio M., Stockwell B. R., Stennicke H. R., Salvesen G. S., Dixit V. M. An induced proximity model for caspase-8 activation. J Biol Chem. 273:1998;2926-2930.
59. Stennicke H. R., Jurgensmeier J. M., Shin H. Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem. 273:1998;27084-27090.
60. Strasser A., Harris A. W., Huang D. C. S., Krammer P. H., Cory S. Bcl-2 and Fas/Apo-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14:1995;6136-6147.
61. Srinivasan A., Li F., Wong A. Bcl-X(L) functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF-7 breast carcinoma cells. J Biol Chem. 273:1998;4523-4529.
62. Boise L. H., Thompson C. B. Bcl-X(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc Nat Acad Sci (USA). 94:1997;3759-3764.
63. Susin S. A., Zamzami N., Castedo M. The central executioner of apoptosis - multiple connections between protease activation and mitochondria in Fas/Apo-1/CD95- and ceramide-induced apoptosis. J Exp Med. 186:1997;25-37.
64. Kuwana T., Smith J. J., Muzio M., Dixit V. M., Newmeyer D. D., Kornbluth S. Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J Biol Chem. 273:1998;16589-16594.
65. Scaffidi C., Fulda S., Srinivasan A. Two CD95 (Apo-1/Fas) signaling pathways. EMBO J. 17:1998;1675-1687.
66. Li H. L., Zhu H., Xu C. J., Yuan J. Y. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
67. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. D. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1998;481-490.
68. Datta R., Banach D., Kojima H. Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents. Blood. 88:1996;1936-1943.
69. Dubrez L., Savoy I., Hamman A., Solary E. Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J. 15:1996;5504-5512.
70. Macfarlane M., Cain K., Sun X. M., Alnemri E. S., Cohen G. M. Processing/Activation of at least four interleukin-1-beta converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells. J Cell Biol. 137:1997;469-479.
71. Faleiro L., Kobayashi R., Fearnhead H., Lazebnik Y. Multiple species of Cpp32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J. 16:1997;2271-2281.
72. Martins L. M., Kottke T., Mesner P. W. Activation of multiple interleukin-1-beta converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J Biol Chem. 272:1997;7421-7430.
73. Droin N., Dubrez L., Eymin B. Upregulation of casp genes in human tumor cells undergoing etoposide-induced apoptosis. Oncogene. 16:1998;2885-2894.
74. Fulda S., Susin S. A., Kroemer G., Debatin K. M. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res. 58:1998;4453-4460.
75. Perkins C., Kim C. N., Fang G. F., Bhalla K. N. Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells. Cancer Res. 58:1998;4561-4566.
76. Fulda S., Sieverts H., Friesen C., Herr I., Debatin K. M. The CD95 (Apo-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res. 57:1997;3823-3829.
77. Muller M., Strand S., Hug H. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (Apo-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest. 99:1997;403-413.
78. Herr I., Wilhelm D., Bohler T., Angel P., Debatin K. M. Activation of CD95 (Apo-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 16:1997;6200-6208.
79. Eischen C. M., Kottke T. J., Martins L. M. Comparison of apoptosis in wild-type and Fas-resistant cells - chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood. 90:1997;935-943.
80. Villunger A., Egle A., Kos M. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells. Cancer Res. 57:1997;3331-3334.
81. Yeh W. C., Delapomp J. L., McCurrach M. E. Fadd - essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science. 279:1998;1954-1958.
82. Smith K. G. C., Strasser A., Vaux D. L. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/Apo-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J. 15:1996;5167-5176.
83. Sané A. T., Schmitt E., Steyaert A., Meyer D., Bertrand R. The CrmA- and TPCK-sensitive pathways that trigger oligonucleosome-sized DNA fragmentation in camptothecin-induced apoptosis - relation to caspase activation and high molecular weight DNA fragmentation. Biochem Cell Biol. 75:1997;359-358.
84. Baserga R. Oncogenes and the strategy of growth factors. Cell. 79:1994;927-930.